Curis (CRIS)

• Market cap: $24M
• 1 day: 6.88%
• 5 days: -1.23%
• 1 month: 17.1%
• 3 months: -33.18%
• 6 months: -59.73%
• Year to date: -38.96%
• 1 year: -71.56%
• 5 years: -99.72%
• 10 years: -99.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 24